DNA Based and Next-Generation Vaccines in Aquaculture Market Key Players Analysis 2026 to 2035
Segmentation of DNA Based and Next-Generation Vaccines in Aquaculture Market:
DNA Based and Next-Generation Vaccines in Aquaculture Market by Vaccines-
- DNA Vaccines
- mRNA / saRNA Vaccines
- Recombinant Subunit Vaccines
- Viral Vector Vaccines
- Bacterial Vector Vaccines
- Others
DNA Based and Next-Generation Vaccines in Aquaculture Market by Pathogen Type-
- Viral Diseases
- Bacterial Diseases
- Parasitic Diseases
DNA Based and Next-Generation Vaccines in Aquaculture Market by Administration Route -
- Injectable Vaccines
- Oral Vaccines
- Immersion / Bath Vaccines
- Mucosal Delivery
- Others
DNA Based and Next-Generation Vaccines in Aquaculture Market by Species -
- Salmonids
- Tilapia
- Carps
- Shrimp
- Seabass / Seabream
- Others
DNA Based and Next-Generation Vaccines in Aquaculture Market By Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global DNA Based and Next-Generation Vaccines in Aquaculture Market Snapshot
Chapter 4. Global DNA Based and Next-Generation Vaccines in Aquaculture Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2026-2035
4.8. Global DNA-Based & Next-Generation Vaccines in Aquaculture Market Penetration & Growth Prospect Mapping (US$ Mn), 2026-2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/impact of AI on DNA-Based & Next-Generation Vaccines in Aquaculture Industry Trends
Chapter 5. DNA Based and Next-Generation Vaccines in Aquaculture Market Segmentation 1: By Vaccine, Estimates & Trend Analysis
5.1. Market Share by Vaccine, 2025 & 2035
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Vaccine:
5.2.1. DNA Vaccines
5.2.2. mRNA / saRNA Vaccines
5.2.3. Recombinant Subunit Vaccines
5.2.4. Viral Vector Vaccines
5.2.5. Bacterial Vector Vaccines
5.2.6. Others
Chapter 6. DNA Based and Next-Generation Vaccines in Aquaculture Market Segmentation 2: By Pathogen Type, Estimates & Trend Analysis
6.1. Market Share by Pathogen Type, 2025 & 2035
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Pathogen Type:
6.2.1. Viral Diseases
6.2.2. Bacterial Diseases
6.2.3. Parasitic Diseases
Chapter 7. DNA Based and Next-Generation Vaccines in Aquaculture Market Segmentation 3: By Administration Route, Estimates & Trend Analysis
7.1. Market Share by Administration Route, 2025 & 2035
7.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Administration Route:
7.2.1. Injectable Vaccines
7.2.2. Oral Vaccines
7.2.3. Immersion / Bath Vaccines
7.2.4. Mucosal Delivery
7.2.5. Others
Chapter 8. DNA-Based & Next-Generation Vaccines in Aquaculture Market Segmentation 4: By Species, Estimates & Trend Analysis
8.1. Market Share by Species, 2025 & 2035
8.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Species:
8.2.1. Salmonids
8.2.2. Tilapia
8.2.3. Carps
8.2.4. Shrimp
8.2.5. Seabass / Seabream
8.2.6. Others
Chapter 9. DNA Based and Next-Generation Vaccines in Aquaculture Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global DNA-Based & Next-Generation Vaccines in Aquaculture Market, Regional Snapshot 2025 & 2035
9.2. North America
9.2.1. North America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022-2035
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Vaccine, 2022-2035
9.2.3. North America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Pathogen Type, 2022-2035
9.2.4. North America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Administration Route, 2022-2035
9.2.5. North America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Species, 2022-2035
9.3. Europe
9.3.1. Europe DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022-2035
9.3.1.1. Norway
9.3.1.2. Greece
9.3.1.3. Spain
9.3.1.4. UK
9.3.1.5. Rest of Europe
9.3.2. Europe DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Vaccine, 2022-2035
9.3.3. Europe DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Pathogen Type, 2022-2035
9.3.4. Europe DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Administration Route, 2022-2035
9.3.5. Europe DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Species, 2022-2035
9.4. Asia Pacific
9.4.1. Asia Pacific DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022-2035
9.4.1.1. China
9.4.1.2. Indonesia
9.4.1.3. Vietnam
9.4.1.4. Japan
9.4.1.5. Korea
9.4.1.6. Rest of Asia Pacific
9.4.2. Asia Pacific DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Vaccine, 2022-2035
9.4.3. Asia Pacific DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Pathogen Type, 2022-2035
9.4.4. Asia Pacific DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Administration Route, 2022-2035
9.4.5. Asia Pacific DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Species, 2022-2035
9.5. Latin America
9.5.1. Latin America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022-2035
9.5.1.1. Chile
9.5.1.2. Brazil
9.5.1.3. Mexico
9.5.1.4. Central AMerica
9.5.1.5. Rest of Latin America
9.5.2. Latin America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Vaccine, 2022-2035
9.5.3. Latin America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Pathogen Type, 2022-2035
9.5.4. Latin America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Administration Route, 2022-2035
9.5.5. Latin America DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Species, 2022-2035
9.6. Middle East & Africa
9.6.1. Middle East & Africa DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022-2035
9.6.1.1. Egypt
9.6.1.2. Turkey
9.6.1.3. GCC countries
9.6.1.4. Rest of Middle East and Africa
9.6.2. Middle East & Africa DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Vaccine, 2022-2035
9.6.3. Middle East & Africa DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Pathogen Type, 2022-2035
9.6.4. Middle East & Africa DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Administration Route, 2022-2035
9.6.5. Middle East & Africa DNA-Based & Next-Generation Vaccines in Aquaculture Market Revenue (US$ Mn) Estimates and Forecasts by Species, 2022-2035
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. MSD/ Merck & Co., Inc.
10.2.1.1. Business Overview
10.2.1.2. Key Vaccine/Service
10.2.1.3. Financial PerPathogen Typeance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Zoetis / PHARMAQ
10.2.3. Ceva Animal Health
10.2.4. Touchlight + Stonehaven (Touchlight Aquaculture)
10.2.5. Vaxxinova
10.2.6. HIPRA
10.2.7. Virbac / Centrovet
10.2.8. Benchmark Animal Health
10.2.9. ViAqua Therapeutics
10.2.10. Tecnovax (NEW)
10.2.11. Nofima
10.2.12. UVAXX
10.2.13. Others
10.2.14. Other prominent players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
DNA Based amd Next-Generation Vaccines in Aquaculture Market is likely to witness the growth at a 10.2% CAGR during the forecast period for 2026-2035
MSD / Merck & Co., Inc., Zoetis / PHARMAQ, Ceva Animal Health, Touchlight + Stonehaven (Touchlight Aquaculture), Vaxxinova, HIPRA, Virbac / Centrovet, Benchmark Animal Health, ViAqua Therapeutics, Tecnovax (NEW), Nofima, UVAXX and Others.
DNA Based and Next-Generation Vaccines in Aquaculture Market is Segmented in Vaccines (DNA Vaccines, mRNA / saRNA Vaccines, Recombinant Subunit Vaccines, Viral Vector Vaccines, Bacterial Vector Vaccines, Others), by Pathogen Type(Viral Diseases, Bacterial Diseases, Parasitic Diseases) by Administration Route (Injectable Vaccines, Oral Vaccines, Immersion / Bath Vaccines, Mucosal Delivery, Others) by Species (Salmonids, Tilapia, Carps, Shrimp, Seabass / Seabream, Others) and Other
North America region is leading the DNA Based and Next-Generation Vaccines in Aquaculture Market.